Abstract
Ricin toxin (RT) is an abundant glycoprotein component of Castor beans (CB) that is highly toxic to mammalian cells. RT is water soluble and does not partition into the oil extract, and there are different isoforms with varied toxicities and antigenicities. RT belongs to the B group of biological warfare agents (BWA). It is made up of two functionally different parts, an A polypeptide chain (RTA: 32 kDa) and a B polypeptide chain (RTB: 34KDa). RTB attaches onto the cell surface, while RTA enters the cell, attaching to ribosomes and inhibiting protein synthesis. A single RTA biomolecule is able to inactivate 1,500–2,000 ribosomes per minute, ultimately leading to cell death. As a BWA, RT is most likely to be deployed as an aerosol; however, it could be administered by other means: ingestion, or possibly even by injection, for assassination. The effectiveness of modified RT for immunochemotherapy has been evaluated. Toxicity and severity of clinical manifestations vary between different routes of administration. Inhalation is the most potent route of entry, and oral ingestion is less toxic and may be nonlethal. RT is detected in tissue sections, body fluids, and nasal swabs of poisoned animals by enzyme-linked immunosorbent assay (ELISA). Treatment of intoxicated patients is very difficult, because RT acts rapidly and irreversibly. The main parts of treatments are decontamination and supportive therapy. Some methods of active and passive immunization have also been investigated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anonymus. Investigation of a ricin-containing envelope at a postal facility – South Carolina. MMWR Morb Mortal Wkly Rep. 2003; 52(46): 1129–1131.
Audi J, Belson M, Patel M, Schier J, Osterloh J. Ricin poisoning: a comprehensive review. JAMA. 2005;294(18):2342–51. doi:10.1001/jama.294.18.2342.
Balali Mood M, Moshiri M, Etemad L. Bio warfare and terrorism: toxins and other mid-spectrum agents. In: Wexler P, Greim H, Moser V, Wiegand TJ, Lafarga JVT, Peyster A, et al. editors. Encyclopedia of toxicology 3rd Edition. Elsevier; Amsterdam 2014 pp 503–508.
Balali-Mood M, Moshiri M, Etemad L. Medical aspects of bio-terrorism. Toxicon. 2013;69:131–42. doi:10.1016/j.toxicon.2013.01.005.
Barbier J, Bouclier C, Johannes L, Gillet D. Inhibitors of the cellular trafficking of Ricin. Toxins (Basel). 2012;4(1):15–27. doi:10.3390/toxins4010015.
Bradberry S. Ricin and abrin. Medicine. 2012;40(2):80–1.
Bradberry SM, Dickers KJ, Rice P, Griffiths GD, Vale JA. Ricin poisoning. Toxicol Rev. 2003;22(1):65–70.
Brandon DL, Korn AM, Yang LL. Detection of ricin contamination in liquid egg by electrochemiluminescence immunosorbent assay. J Food Sci. 2012;77(4):T83–8. doi:10.1111/j.1750-3841.2012.02627.x.
Carra JH, Wannemacher RW, Tammariello RF, Lindsey CY, Dinterman RE, Schokman RD, et al. Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity. Vaccine. 2007;25(21):4149–58. doi:10.1016/j.vaccine.2007.03.011.
Challoner KR, McCarron MM. Castor bean intoxication. Ann Emerg Med. 1990;19(10):1177–83.
Chow SK, Casadevall A. Monoclonal antibodies and toxins–a perspective on function and isotype. Toxins (Basel). 2012;4(6):430–54. doi:10.3390/toxins4060430.
Christiansen VJ, Hsu CH, Dormer KJ, Robinson CP. The cardiovascular effects of ricin in rabbits. Pharmacol Toxicol. 1994;74(3):148–52.
Coopman V, De Leeuw M, Cordonnier J, Jacobs W. Suicidal death after injection of a castor bean extract (Ricinus communis L.). Forensic Sci Int. 2009;189(1–3):e13–20.
Crompton R, Gall D. Georgi Markov–death in a pellet. Med Leg J. 1980;48(2):51–62.
Doan LG. Ricin: mechanism of toxicity, clinical manifestations, and vaccine development. A review. J Toxicol Clin Toxicol. 2004;42(2):201–8.
Ferraz AC, Angelucci ME, Da Costa ML, Batista IR, De Oliveira BH, Da Cunha C. Pharmacological evaluation of ricinine, a central nervous system stimulant isolated from Ricinus communis. Pharmacol Biochem Behav. 1999;63(3):367–75.
Griffiths GD, Lindsay CD, Allenby AC, Bailey SC, Scawin JW, Rice P, et al. Protection against inhalation toxicity of ricin and abrin by immunisation. Hum Exp Toxicol. 1995;14(2):155–64.
Griffiths GD, Phillips GJ, Holley J. Inhalation toxicology of ricin preparations: animal models, prophylactic and therapeutic approaches to protection. Inhal Toxicol. 2007;19(10):873–87. doi:10.1080/08958370701432124.
Hassoun EA, Stohs SJ. Potential chemoprotectant activity of 3′-azido-3′-deoxythymidine (AZT) and 2′,3′-dideoxycytidine (DDC) against ricin toxicity in Chinese hamster ovary and macrophage J774A.1 cell cultures. J Appl Toxicol. 1996;16(1):43–8.
He X, McMahon S, Henderson 2nd TD, Griffey SM, Cheng LW. Ricin toxicokinetics and its sensitive detection in mouse sera or feces using immuno-PCR. PLoS One. 2010a;5(9):e12858. doi:10.1371/journal.pone.0012858.
He X, McMahon S, McKeon TA, Brandon DL. Development of a novel immuno-PCR assay for detection of ricin in ground beef, liquid chicken egg, and milk. J Food Prot. 2010b;73(4):695–700.
Legler PM, Brey RN, Smallshaw JE, Vitetta ES, Millard CB. Structure of RiVax: a recombinant ricin vaccine. Acta Crystallogr D Biol Crystallogr. 2011;67(Pt 9):826–30. doi:10.1107/S0907444911026771.
Lord JM, Roberts LM, Robertus JD. Ricin: structure, mode of action, and some current applications. FASEB J. 1994;8(2):201–8.
Lord MJ, Jolliffe NA, Marsden CJ, Pateman CS, Smith DC, Spooner RA, et al. Ricin. Mechanisms of cytotoxicity. Toxicol Rev. 2003;22(1):53–64.
Olsnes S. The history of ricin, abrin and related toxins. Toxicon. 2004;44(4):361–70. doi:10.1016/j.toxicon.2004.05.003.
Olsnes S, Kozlov JV. Ricin. Toxicon. 2001;39(11):1723–8.
Papaloucas M, Papaloucas C, Stergioulas A. Ricin and the assassination of Georgi Markov. Pak J Biol Sci. 2008;11(19):2370–1.
Pincus SH, Smallshaw JE, Song K, Berry J, Vitetta ES. Passive and active vaccination strategies to prevent ricin poisoning. Toxins (Basel). 2011;3(9):1163–84. doi:10.3390/toxins3091163.
Poli MA, Roy H, Huebner KD, Franz DR, Jaax NK. Chapter 15, Ricin. In: Lenhart MK, editor. Medical aspects of biological warfare. Washington, DC: Borden Institute, Office of the Surgeon General, AMEDD Center & School, US Army; 2008. p. 323–35.
Rana M, Dhamija H, Prashar B, Sharma S. Ricinus communis L. Int J PharmTech Res. 2012;4(4):1706–11.
Saeidnia S, Abdollahi M. How dangerous could be the receiving of a Ricin-Contaminated letter? Iran J Biotechnol. 2013;11(3):141–3. doi:10.5812/ijb.13755.
Scarpa A, Guerci A. Various uses of the castor oil plant (Ricinus communis L.). J Ethnopharmacol. 1982;5(2):117–37.
Sehgal P, Khan M, Kumar O, Vijayaraghavan R. Purification, characterization and toxicity profile of ricin isoforms from castor beans. Food Chem Toxicol. 2010;48(11):3171–6. doi:10.1016/j.fct.2010.08.015.
Shah SA, Halloran PM, Ferris CA, et al. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models. Cancer Res. 1993;53(6):1360–7.
Smallshaw JE, Richardson JA, Vitetta ES. RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol. Vaccine. 2007;25(42):7459–69.
Stechmann B, Bai SK, Gobbo E, Lopez R, Merer G, Pinchard S, et al. Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell. 2010;141(2):231–42. doi:10.1016/j.cell.2010.01.043.
Stewart CC. Weapons of mass casualties and terrorism response handbook. Sudbury: Jones & Bartlett; 2005.
Vitetta ES, Smallshaw JE, Coleman E, Jafri H, Foster C, Munford R, et al. A pilot clinical trial of a recombinant ricin vaccine in normal humans. Proc Natl Acad Sci U S A. 2006;103(7):2268–73. doi:10.1073/pnas.0510893103.
Wilhelmsen CL, Pitt ML. Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys. Vet Pathol. 1996;33(3):296–302.
Worbs S, Kohler K, Pauly D, Avondet MA, Schaer M, Dorner MB, et al. Ricinus communis intoxications in human and veterinary medicine-a summary of real cases. Toxins (Basel). 2011;3(10):1332–72. doi:10.3390/toxins3101332.
Yoshida M, Rybak RJ, Choi Y, et al. Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assay. Cancer Res. 1997;57(4):678–85.
Zilinskas RA. Iraq’s biological weapons. The past as future? JAMA. 1997;278(5):418–24.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Moshiri, M., Etemad, L., Balali-Mood, M. (2015). The Biowarfare Agent Ricin. In: Gopalakrishnakone, P., Balali-Mood, M., Llewellyn, L., Singh, B.R. (eds) Biological Toxins and Bioterrorism. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5869-8_6
Download citation
DOI: https://doi.org/10.1007/978-94-007-5869-8_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5868-1
Online ISBN: 978-94-007-5869-8
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences